Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...

The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...

China said on Wednesday it would further enhance capital market support for science and technology innovation enterprises and ...

The Commission is found to have wrongly refused to publish texts from its president during the Covid pandemic.

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

Risk for the autoimmune hair disorder was reduced by nearly 75% in patients on these treatments for psoriasis, finds a ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The European Union General Court rejected on Wednesday a European Commission decision not to disclose text messages ...